The trial was halted due to inadequate efficacy, Jay Bradner, M.D., Amgen’s executive vice president of R&D, said during a Nov. 4 call with investors, after an ad hoc analysis requested by an internal ...

Agentic AI is reshaping the data landscape, impacting professionals across every industry. Here's what the changes mean for your organization.

Incyte (Nasdaq:INCY) today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual ...

The world of sports is quickly changing, and you can see the change clearly in how teams use data to gain an edge. From ...

AI-driven precision-oncology analysis identifies patient subtypes with potential enhanced response to glufosfamide ...

American Critical Minerals has voluntarily filed a National Instrument 43-101 Technical Report supporting the exploration targets for Potash, Lithium and Bromine. 2.1 billion cubic meters (brine ...

GLP-1 receptor agonists may have beneficial effects against Alzheimers, psychiatric and addiction disorders, but early data ...

CHICAGO -- Plaque psoriasis drug deucravacitinib (Sotyktu) now looks likely to win a psoriatic arthritis (PsA) indication in ...

Analysis of the data from the open-label pivotal trial of oxylanthanum carbonate (OLC) highlights that pill burden was significantly reduced in terms of both pill volume (7x) and pill count (2x) from ...

Schneider Electric's organic revenue growth beat quarterly estimates on Thursday, propelled by surging demand for data ...

Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the ...